Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolytic compounds

Journal of Cannabis Therapeutics

Volumn 4, Issue 1, 2004, Pages 7-27

  Gieringer, Dale ^a   St Laurent, Joseph ^b   Goodrich, Scott ^b  

^a California NORML   (United States)

^b Building 7   (United States)

Author keywords

Cannabis; Harm reduction; Marijuana; Smoking; Vaporization

Indexed keywords

1 METHYLNAPHTHALENE; ALPHA TOCOPHEROL; BETA AMYRIN; CAFFEINE; CANNABIDIOL; CANNABINOID; CANNABINOL; CANNABIS; CARYOPHYLLENE; CARYOPHYLLENE OXIDE; CHOLESTEROL; DRONABINOL; HERBACEOUS AGENT; HEXADECANE; HEXADECANOL; INDOLE; MYRISTIC ACID; NAPHTHALENE; PHTHALIC ACID DIBUTYL ESTER; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE DERIVATIVE; SQUALENE; TOXIC GAS;

ANALYTIC METHOD; ARTICLE; COMBUSTION; CONTROLLED STUDY; DIODE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG IDENTIFICATION; GAS; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MASS SPECTROMETER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID; STANDARD; TEMPERATURE; VAPOR; VAPORIZATION; VAPORIZER;

EID: 1942500215     PISSN: 15299775     EISSN: None     Source Type: Journal    
DOI: 10.1300/J175v04n01_02     Document Type: Article

References (17)

1. Chemic Laboratories. 2000. Proof of concept: release of chemical constituents in cannabis sativa at 170-185° versus combustion. Unpublished report to California NORML and MAPS, Nov. 17th, 2000.
2. Chemic Laboratories. 2003. Evaluation of Volcano® vaporizer for the efficient emission of THC, CBD, CBN and the significant reduction and/or elimination of polynuclear-aromatic (PNA) analytes resultant of pyrolysis. Unpublished report to California NORML and MAPS, Apr 8th, 2003.
3. Davis, K.H. et al. 1984. Some smoking characteristics of marijuana cigarettes. In Agurell, S., Dewey, W.L. and Willette, R.E., eds. The Cannabinoids: Chemical Pharmacologic and Therapeutic Aspects. NY: Academic Press.
4. ElSohly, M. 2002. Chemical constituents of cannabis. In Grotenhermen, F. and Russo, E., eds. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. NY: The Haworth Press.
5. Fehr, K.O. and Kalant, H. 1972. Analysis of cannabis smoke obtained under different combustion conditions. Can J Physiol Pharmacol 50: 761-7.
6. Gieringer, D. 1996. Marijuana research: waterpipe study. MAPS (Multidisciplinary Association for Psychedelic Studies) Bul 6(3): 59-66.
7. Gieringer, D. 2001. Cannabis vaporization: a promising strategy for smoke harm reduction. J Cannabis Therap 1(3-4): 153-70.
8. Huber, G., M. First and O. Grubner. 1991. Marijuana and tobacco smoke gas-phase cytotoxins. Pharmacol Biochem Behav 40(3): 629-36.
9. Institute of Medicine. 1982. Marijuana and Health. Washington, DC: National Academy Press.
10. Institute of Medicine. 1999. Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press.
11. Manno, J.E. et al. 1970. Comparative effects of smoking marihuana or placebo on human motor performance. Clin Pharmacol Ther 11: 808-15.
12. Perez-Reyes, M. 1990. Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. In C.N. Chiang and R.L. Hawks, eds. Research Findings on Smoking of Abused Substances. NIDA Research Monograph 99:42-62.
13. Polen, M. et al. 1993. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med 158(6): 596-601.
14. Russo, E. 2003. An interview with Markus Storz: June 19, 2002. J Cannabis Therap 3(1): 67-78.
15. Tashkin, D.P. et al. 1977. Bronchial effects of aerolized delta-9-tetrahydrocannabinol in healthy and asthmatics subjects. Amer Rev Resp Dis 115:57-65.
16. Tashkin, D. 1993. Is frequent marijuana smoking hazardous to health? West J Med 158(6): 635-7.
17. Truitt, E. 1971. Biological disposition of tetrahydrocannabinols. Pharmacol Rev 23(4): 273-8.